Join to view full profile
2106 Harrisburg PikeSuite 116Lancaster, PA 17601
Phone+1 717-544-3600
Fax+1 717-544-3604
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Nandi Reddy, MD is an oncologist in Lancaster, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania, New Hampshire, and Texas.
Education & Training
University of Texas Southwestern Medical CenterResidency, Gastroenterology, 2019 - 2025
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalFellowship, Hematology and Medical Oncology, 2007 - 2010
Texas Tech University (Permian Basin)Residency, Internal Medicine, 1998 - 2000- Edgewater HospitalInternship, Internal Medicine, 1997 - 1998
Siddhartha Medical College NTRClass of 1996
Certifications & Licensure
NH State Medical License 2005 - Present
PA State Medical License 2010 - 2026
TX State Medical License 2000 - 2026
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2017
Publications & Presentations
PubMed
- 25 citationsPreemptive pharmacogenetic testing to guide chemotherapy dosing in patients with gastrointestinal malignancies: a qualitative study of barriers to implementation.Kelsey S Lau-Min, Lisa A Varughese, Maria N Nelson, Christine Cambareri, Nandi J Reddy
BMC Cancer. 2022-01-08 - 19 citationsImplementing Pharmacogenetic Testing in Gastrointestinal Cancers (IMPACT-GI): Study Protocol for a Pragmatic Implementation Trial for EstablishingandScreening to Guide...Lisa A Varughese, Madhuri Bhupathiraju, Glenda Hoffecker, Shannon Terek, Margaret Harr
Frontiers in Oncology. 2022-01-01 - 22 citationsDPYD and UGT1A1 Pharmacogenetic Testing in Patients with Gastrointestinal Malignancies: An Overview of the Evidence and Considerations for Clinical ImplementationLisa A. Varughese, Kelsey S. Lau-Min, Christine Cambareri, Nevena Damjanov, Ryan Massa
Pharmacotherapy. 2020-11-01
Press Mentions
How to Get Medical Marijuana: Find Central Pa. Dispensaries, Doctors Who PrescribeOctober 2nd, 2018
